Touchstone International Medical Science Co Ltd (688013) — Capital Reinvestment Ratio
Touchstone International Medical Science Co Ltd (688013) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥27.05 Million) in capital expenditures (CN¥8.28 Million). See 688013 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Touchstone International Medical Science Co Ltd Capital Reinvestment Ratio (2017–2024)
This chart tracks Touchstone International Medical Science Co Ltd's Capital Reinvestment Ratio across 8 annual periods. Check 688013 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Touchstone International Medical Science Co Ltd (2017–2024)
Year-by-year Capital Reinvestment Ratio for Touchstone International Medical Science Co Ltd from 2017 to 2024. For live market cap and broader valuation context, see market cap of Touchstone International Medical Science.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.79x | CN¥53.41 Million | CN¥41.94 Million | ▲ +253.8% |
| 2023 | 0.22x | CN¥82.95 Million | CN¥18.41 Million | ▼ -76.5% |
| 2022 | 0.95x | CN¥50.40 Million | CN¥47.67 Million | ▲ +526.2% |
| 2021 | 0.15x | CN¥60.98 Million | CN¥9.21 Million | ▼ -12.9% |
| 2020 | 0.17x | CN¥42.08 Million | CN¥7.29 Million | ▼ -35.9% |
| 2019 | 0.27x | CN¥34.82 Million | CN¥9.41 Million | ▼ -55.2% |
| 2018 | 0.60x | CN¥34.44 Million | CN¥20.78 Million | ▼ -68.7% |
| 2017 | 1.93x | CN¥7.88 Million | CN¥15.21 Million | — |